Moderna is chewing over a nearly five-fold price increase for its COVID-19 vaccine as the company prepares to roll the jabs out to commercial buyers, and is considering a number between $110 and $130, according to reports.
In interviews at the JPMorgan Healthcare Conference in San Francisco on Monday, chief executive Stephane Bancel said the range seemed “reasonable given the value being created by the vaccines,”reported. The estimate matches that given in October by rival drugmaker Pfizer, which is similarly gearing up to shift from government to commercial distribution.
Pfizer said at the time that the earliest it would be prepared to put its vaccine on the commercial market would be early this year, depending on factors such as the length of its contracts with the federal government, as well as the longevity of the current U.S. supply. Moderna’s government contracts, according to, price the jab significantly lower, with booster shots costing roughly $26 per dose.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
WSJ: Moderna may charge up to $130 per dose of its COVID shotShares of Moderna Inc. were up 2.5% in trading on Monday afternoon after the Wall Street Journal reported that the company is considering pricing its...
Les mer »
WSJ News Exclusive | Moderna Considers Price of $110-$130 for Covid-19 VaccineModerna is considering a price of $110-$130 for its Covid-19 vaccine after distribution shifts from government contracting to the commercial market
Les mer »
Moderna considers pricing COVID vaccine at $110-$130 - WSJModerna Inc is considering pricing its COVID-19 shot at $110 to $130 per dose in the United States when it shifts from government contracting to commercial distribution of the shots, the company's Chief Executive Officer Stephane Bancel told the Wall Street Journal on Monday.
Les mer »
Moderna’s COVID shot to generate $5.0 billion in sales in 2023Shares of Moderna Inc. were up about 1.0% in premarket trading on Monday after the company reiterated that it expects to have $5.0 billion in sales of its...
Les mer »
Moderna’s Bancel Prepares for Transition Year as COVID Vaccine Sales Wane(Bloomberg) — Moderna Inc. is looking for potential approval of two new vaccines this year to help compensate for waning sales of its Covid-19 shot, according to Chief Executive Officer Steph…
Les mer »
Does a Video Show Baby Giraffes Frolicking in a Park?❌ This viral video doesn't feature real baby giraffes. Rather, it's the work of a digital artist.
Les mer »